LITTLE KNOWN FACTS ABOUT LINK ALTERNATIF MBL77.

mutations and sophisticated kar yotype. It follows a linear evolution in the CLL clone from the recurrent acquisition of CDKN2ANot all individuals with CLL have to have therapy. Even with all recent innovations, the iwCLL however suggests watchful observation for patients with asymptomatic disorder.86 This suggestion is based on no less than two ra